Ignite Creation Date:
2024-05-06 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05165433
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-02
First Post:
2021-12-07
Brief Title:
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours FORTIFY
Sponsor:
Akamis Bio
Organization:
Akamis Bio
Organization Data
Organization:
Akamis Bio
Class:
INDUSTRY
Study ID:
NG-350A-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Akamis Bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |